Table 3 Clinical parameters before and after PN supplementation. Patients in the PN group received PN supplementation equivalent to 40% or 50% of the resting energy requirement (RER), while patients in the Control Group did not receive supplementation

 Mean ± SD

3.8 ± 1.7

4.1 ± 1.2

0.508

N/A

 Male

6 (26.1%)

15 (41.7%)

0.223

N/A

 Female

17 (73.9%)

21 (58.3%)

 Mean ± SD

0.35 ± 0.07

0.33 ± 0.05

0.204

0.34 ± 0.07

0.32 ± 0.05

0.237

0.37–0.55 L/L

 Mean ± SD

118.1 ± 24.3

109.7 ± 19.0

0.909

113.6 ± 26

108 ± 19.3

0.572

120–180 g/L

 Mean ± SD

5.3 ± 1.1

5.8 ± 1.1

0.0856

5.1 ± 1.3

5.6 ± 1.2

0.139

5.5–8.5 X1012/L

 Median [IQR]

5.8 [1.9–8.9]

10.3 [6.0–14.4]

0.014

9.1 [5.3–12.4]

10.3 [5.6–15.2]

0.148

6.0–17.0 X10⁹/L

 Median [IQR]

2.5 [0.5–6.0]

6.9 [4.1–9.9]

< 0.001

5 [3–6]

7 [4.2–10.5]

0.021

3.0–11.5 X10⁹/L

 Median [IQR]

0 [0–0.3]

0.15 [0–1.38]

0.084

0 [0–0.3]

0.3 [0–1.2]

0.015

0.0–0.3 X10⁹/L

 Median [IQR]

1.74 [0.8–2.9]

2 [1.1–3.5]

0.222

2.4 [1.8–4.7]

2.1 [1.1–3.2]

0.086

1.0–4.8 X10⁹/L

 Median [IQR]

0.16 [0–0.5]

0 [0–0]

< 0.001

0.2 [0–0.7]

0 [0–0]

< 0.001

0.1–1.4 X10⁹/L

 Median [IQR]

0 [0–0]

0 [0–0.08]

0.192

0 [0–0]

0 [0–0]

0.629

0.0–0.9 X10⁹/L

 Median [IQR]

0 [0–0]

0 [0–0]

0.424

0 [0–0]

0 [0–0]

–

0.0 X10⁹/L

 Mean ± SD

281.6 ± 141.7

268 ± 109.6

0.706

277.9 ± 119.1

283.1 ± 112.8

0.870

200–600 X10⁹/L

 Median [IQR]

0 [0–11.5]

–

–

0 [0–16]

–

–

< 60 X10⁹/L

 mean ± SD

48.8 ± 11.1

47.6 ± 5.0

0.254

44.2 ± 6.8

38.9 ± 5.4

0.123

49–68 g/L